Panminerva Medica 2016 September;58(3):242-3

language: English

Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry

Andrea RUBBOLI ¹, Cataldo PALMIERI ², Giancarlo PIOVACCARI ³, Giuseppe DI PASQUALE ⁴, Carlo BRIGUORI ⁵, Massimo MARGHERI ⁶ ✉, for the WARfarin and coronary STENTing (WAR-STENT) Study Group

¹ Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy; ² Division of Cardiology, Ospedale del Cuore “G. Pasquinucci”, Massa, Italy; ³ Division of Cardiology, Ospedale degli Infermi, Rimini, Italy; ⁴ Division of Cardiology, Ospedale Maggiore, Bologna, Italy; ⁵ Department of Cardiology, Clinica Mediterranea, Napoli, Italy; ⁶ Department of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy

PDF

top of page

YOUR ACCOUNT

YOUR ORDERS

SHOPPING BASKET

HOW TO ORDER

YOUR SUBSCRIPTIONS

YOUR ARTICLES

YOUR EBOOKS

COUPON

ACCESSIBILITY

Panminerva Medica 2016 September;58(3):242-3

Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry

Publication History

Cite this article as

for the WARfarin and coronary STENTing (WAR-STENT) Study Group

Corresponding author e-mail